United StatesLacosamide Tablets, USP, 100 mg, Rx only, 60-count bottles (NDC 31722-813-60) manufactured by Annora Pharma Pvt. Ltd. for Camber Pharmaceuticals, Lot A253999 and A254000, expiring 09/30/2027, sold nationwide in the U.S., are being recalled. The recall was issued because a complaint indicated a possible mix-up with Selexipag 1000 mcg tablets found in bottles of Lacosamide tablets.
What's being recalled
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Recalling firm: Annora Pharma Private Limited, Hyderabad, N/A, India.
How to identify it
Lot: A253999, A254000, Expires: 09/30/2027.
The hazard
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)